Low molecular weight heparin [3]

Annals of Emergency Medicine

Volumn 36, Issue 3, 2000, Pages 277-

  Vanpee, D ^a   Gillet, J B ^a   Swine, C ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE;

ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; CREATININE CLEARANCE; DRUG EFFICACY; DRUG SAFETY; HYPOTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL;

EID: 0033812398     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2000.109264     Document Type: Letter

References (5)

1. HC. Hovanessian New-generation anticoagulants: the low molecular weight heparins Ann Emerg Med 34 1999 768 779
2. GF Pineo RD. Hull Unfractionated and low-molecular-weight heparin. Comparisons and current recommendations. Med Clin North Am 82 1998 587 599
3. Y Cadroy J Pourrat MF Baladre Delayed elimination of enoxaparin in patients with chronic renal insufficiency Thromb Res 63 1991 385 390
4. J Van Ryn-McKenna L Cai FA Ofosu Neutralization of enoxaparin-induced bleeding by protamine sulfate Thromb Haemost 63 1990 271 274
5. J Hoist B Lindblad D Bergqvist Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin). An experimental investigation in healthy volunteers. Blood Coagul Fibrinolysis 5 1994 795 803